Company: DERM
Filing Date: 2025-08-28
Form Type: 424B3
Source: 0001104659-25-084876
Chunk: 31

Company: Journey Medical Corp
Filing Date: 2025-08-28
Form: 424B3
Chunk 31
---
.
The JOBS Act contains provisions that, among other things, reduce certain reporting requirements for an “emerging growth
company.” For so long as we remain an emerging growth company, we are permitted and plan to rely on exemptions from certain disclosure
requirements that are applicable to other public companies that are not emerging growth companies.

These exemptions include reduced disclosure
obligations regarding executive compensation. In addition, as an emerging growth company, we are not required to conduct votes seeking
approval, on an advisory basis, of the compensation of our named executive officers or the frequency with which such votes must be conducted.
We may take advantage of some or all of these exemptions until such time as we are no longer an emerging growth company.

We are also a “smaller reporting company,”
meaning that the market value of our stock held by non-affiliates is less than $700 million and our annual revenue was less
than $100 million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either (i) the
market value of our stock held by non-affiliates is less than $250 million or (ii) our annual revenue was less than $100
million during the most recently completed fiscal year and the market value of our stock held by non-affiliates was less than
$700 million. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on
exemptions from certain disclosure requirements that are available to smaller reporting companies. For so long as we remain a smaller
reporting company, we are permitted and intend to rely on exemptions from certain disclosure and other requirements that are applicable
to other public companies that are not applicable to a smaller reporting company.

<div align='center'>4

RISK FACTORS</div>

Investing in our securities involves risks. You
should carefully consider the risks, uncertainties and other factors described in our most recent Annual Report on Form 10-K, as
supplemented and updated by subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K that we have filed or
will file with the SEC, and in other documents which are incorporated by reference into this prospectus, as well as the risk factors and
other information contained in or incorporated by reference into any accompanying prospectus supplement before investing in any of our
securities. Our business, financial condition, results of operations, cash flows or prospects could be materially and adversely affected
by any of these risks